Prognostic and clinicopathological features of E-cadherin, α -catenin, β-catenin, γ-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma

59Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Aim: To investigate the expression of E-cadherin, α-catenin, β-catenin, γ-catenin and cyclin D1 in patients with esophageal squamous cell carcinoma (ESCC), and analyze their interrelationship with clinicopathological variables and their effects on prognosis. Methods: Expression of E-cadherin, α-catenin, β-catenin, γ-catenin and cyclin D1 was determined by EnVision or SABC immunohistochemical technique in patients with ESCC consecutively, their correlation with clinical characteristics was evaluated and analyzed by univariate analysis. Results: The reduced expression rate of E-cadherin, α-catenin, β-catenin and γ-catenin was 88.7%, 69.4%, 35.5% and 53.2%, respectively. Cyclin D1 positive expression rate was 56.5%. Expression of γ-catenin was inversely correlated with the degree of tumor differentiation and lymph node metastasis (χ2 = 4.183 and χ2 = 5.035, respectively, P<0.05), whereas the expression of E-cadherin was correlated only with the degree of differentiation (χ2 = 5.769, P<0.05). Reduced expression of E-cadherin and γ-catenin was associated with poor differentiation of tumor, reduced expression of γ-catenin was also associated with lymph node metastasis. There obviously existed an inverse correlation between level of E-cadherin and γ-catenin protein and survival. The 3-year survival rates were 100% and 56% in E-cadherin preserved expression group and in reduced expression one and were 78% and 48% in γ-catenin preserved expression group and in reduced expression one, respectively. The differences were both statistically significant. Correlation analysis showed the expression level of α-catenin correlated with that of E-cadherin and β -catenin (P<0.05). Conclusion: The reduced expression of E-cadherin and γ-catenin, but not α-catenin, β-catenin and cyclin D1, implies more aggresive malignant behaviors of esophagel carcinoma cells and predict the poor prognosis of patients. clinicopathological features of E-cadherin, α-catenin, β-catenin, γ-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. Copyright © 2004 by The WJG.

Cite

CITATION STYLE

APA

Lin, Y. C., Wu, M. Y., Li, D. R., Wu, X. Y., & Zheng, R. M. (2004). Prognostic and clinicopathological features of E-cadherin, α -catenin, β-catenin, γ-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World Journal of Gastroenterology, 10(22), 3235–3239. https://doi.org/10.3748/wjg.v10.i22.3235

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free